ARF6 and neoplasm: Furthermore, to investigate the potential application of targeting the ARF6 pathway in immunotherapy, we conducted experiments, in collaboration with Ono Pharmaceutical, using a tumor formation model with KPC cells transplanted into syngeneic mice so to evaluate the anticancer effect of ICIs.